← SynDRA
PRALIDOXIME
SynDRA canonical compound SYN0006367 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Approval status | Approved · Rx/OTC |
|---|
| Primary target(s) | ACHE |
|---|
| Mechanism of action | Acetylcholinesterase inhibitor |
|---|
| Indication | organophosphate poisoning |
|---|
| Disease area | critical care |
|---|
All known targets
Mechanisms of action (all sources)
- Acetylcholinesterase inhibitor
- ACHE ACTIVATOR
- Acetylcholinesterase activator
- ACHE INHIBITOR
- ACHE MODULATOR
Drug classes
- Cholinesterase Reactivators
- Antidotes
- Cholinergic Agents
- Neurotransmitter Agents
- Protective Agents
- Cholinesterase Reactivator
ATC classes
- V03A · ALL OTHER THERAPEUTIC PRODUCTS
Cross-references
Synonyms
- pralidoxime iodide
- pralidoxime chloride
- Atnaa
- Pralidoxime cation
- Pralidoxime ion
- P7MU9UTP52
- Spectrum_001144
- Prestwick0_000943
- Prestwick1_000943
- Spectrum2_000921
- Spectrum3_001498
- Spectrum4_000323
- KBioGR_000665
- KBioSS_001624
- DivK1c_000770
- SCHEMBL439969
- SPBio_000822
- SPBio_003065
- N-methyl-pyridinium-2-aldoxime
- GTPL4652
- orb1744464
- SCHEMBL31456539
- KBio1_000770
- KBio2_001624
- KBio2_004192
- KBio2_006760
- KBio3_002615
- N-[(1-methylpyridin-1-ium-2-yl)methylidene]hydroxylamine
- JBKPUQTUERUYQE-UHFFFAOYSA-O
- JBKPUQTUERUYQE-VOTSOKGWSA-O
- NINDS_000770
- [(1-methyl-1,2-dihydropyridin-2-ylidene)methyl](oxo)azanium
- Pralidoximum
- 2-PAM
- CHEBI:8354
- (1-methylpyridin-2-ylidene)methyl-oxoazanium
- 1-methylpyridinium-2-aldoxime ion
- 2-Pam bromide
Look up PRALIDOXIME in the interactive SynDRA portal →